Windtree Therapeutics, Inc.
WINT
$0.8522
$0.00330.39%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 8.24M | 8.42M | 8.23M | 9.06M | 9.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.52M | 25.36M | 25.31M | 18.04M | 17.34M |
| Operating Income | -24.52M | -25.36M | -25.31M | -18.04M | -17.34M |
| Income Before Tax | -1.79M | -9.64M | -11.07M | -5.85M | -20.29M |
| Income Tax Expenses | -6.00K | 71.00K | 311.00K | 114.00K | -- |
| Earnings from Continuing Operations | -1.79 | -9.71 | -11.38 | -5.96 | -20.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.79M | -9.71M | -11.38M | -5.96M | -20.29M |
| EBIT | -24.52M | -25.36M | -25.31M | -18.04M | -17.34M |
| EBITDA | -24.35M | -25.18M | -25.17M | -17.96M | -17.26M |
| EPS Basic | -1.26K | -1.26K | -1.05K | -- | -- |
| Normalized Basic EPS | -734.33 | -750.58 | -642.77 | -- | -- |
| EPS Diluted | -1.26K | -1.26K | -1.05K | -- | -- |
| Normalized Diluted EPS | -734.33 | -750.58 | -642.77 | -- | -- |
| Average Basic Shares Outstanding | 201.00K | 29.20K | 11.50K | -- | -- |
| Average Diluted Shares Outstanding | 201.00K | 29.20K | 11.50K | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -36.77% | -3.57% | -- | -- | -- |